Hepatitis C Virus (HCV), IgM Qualitative - Book Test at Low Cost

What does the qualitative HCV test entail?

The qualitative HCV RNA testing will show if the hepatitis C virus is in the bloodstream or not. On the result, it says "detected" or "not detected."

Tell us about the HCV IgM test.

What is an IgM test for the anti-HCV virus? Antibodies to the virus can be discovered via a blood test called an anti-HCV IgM test. Liver cancer has been linked to the HCV virus. The anti-HCV IgM test can identify people who may have had hepatitis C infection but have not yet shown symptoms.

Is HCV a harmful condition?

Chronic hepatitis C may result in long-term health problems such as liver damage, liver failure, cirrhosis, and liver cancer.

If you have HCV, is it curable?

No of their HCV genotype, over 90% of patients with hepatitis C virus (HCV) infection can become cured with 8–12 weeks of oral treatment

What are the four stages of Hep C?

Stage 1 is characterized by moderate fibrosis without scarred walls and mild to moderate fibrosis with scarred walls. Stage 3: bridging fibrosis or the spread of scarring to other parts.

Several warning indicators and symptoms include:

• readily bruising
• prone to bruising
• Lack of appetite and fatigue
• yellowish discoloration of the eyes and skin (jaundice)
• urine that is a rich hue
• abdominal swelling and skin itch (ascites)
• You have swelling legs.
• Gain less weight
• Anxiety, perplexity, and slurred speech (hepatic encephalopathy)
• Blood veins in your skin resemble spiders (spider angiomas)

Exists a treatment for HCV?

Over 90% of people with hepatitis C (HCV) infection can be cured with 8–12 weeks of oral treatment, regardless of their HCV genotype.

Causes and spread of Hepatitis C?

Blood is the source of transmission of this infection. The most common spread is by sharing needles.

What are the four stages of Hep C?

Moderate fibrosis without walls made of scar tissue is stage 1. Stage 2 includes mild to severe fibrosis with walls of scarring. Stage 3: a widespread proliferation of scarring or bridging fibrosis.